ClinicalTrials.govpublic full text
Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia
adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with del(5q), adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), adult acute promyelocytic leukemia (m3), recurrent adult acute myeloid leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898835
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.